Molecular mechanisms of memory formation and tolerance in CRISPR-Cas systems

CRISPR-Cas系统中记忆形成和耐受的分子机制

• 批准号: 10570544
• 负责人: Naama Aviram
• 金额: $ 12.5万
• 依托单位: ROCKEFELLER UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-01 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10570544
• 关键词: Adaptive Immune System; Affect; Archaea; Autoimmunity; Bacteria; Bacterial Genome; Bacteriophages; Biochemical; Biochemistry; Bioinformatics; Biology; Biophysics; CRISPR/Cas technology; Cells; Characteristics; Classification; Clustered Regularly Interspaced Short Palindromic Repeats; Communication; Complex; DNA; DNA Repair; DNA Sequence; DNA-Directed RNA Polymerase; Data; Development; Elements; Engineering; Environment; Genes; Genetic; Genetic Transcription; Genome; Genomics; Goals; Health; Human; Immune response; Immune system; Immunity; Immunologic Memory; Impairment; Infection; Integrase; Integration Host Factors; Invaded; Laboratories; Link; Location; Mediating; Memory; Mentorship; Mobile Genetic Elements; Molecular; Molecular Biology; Nucleic Acids; Outcome; Pathogenicity; Physiological; Plasmids; Population; Process; RNA; Research; Research Design; Ribosomal RNA; Role; Site; Staphylococcus epidermidis; System; Testing; Transcript; Transfer RNA; Universities; Work; Writing; biological systems; career; cold shock protein; cost; ds-DNA; experimental study; fitness; genome editing; genome wide screen; genotoxicity; improved; insight; memory acquisition; molecular diagnostics; nuclease; prevent; promoter; recruit; recurrent infection; skills; technology development; tool

Project Summary CRISPR-Cas are prokaryotic adaptive immune systems that protect bacteria and archaea from invading mobile genetic elements, such as phages and plasmids. CRISPR-Cas systems acquire immunological memories during infection by integrating short fragments from the invader’s genome into the CRISPR locus of the host. These fragments, called “spacers”, are later transcribed into CRISPR RNAs that are loaded on Cas nucleases and guide them to recognize and cleave infecting nucleic acids. Depending on their genetic composition, CRISPR- Cas systems are classified into six types (I-VI). While spacer acquisition has been extensively studied in type I and II systems, type III systems are just now starting to be explored. The overall goal of this application is to define the molecular mechanisms that govern spacer acquisition by the prevalent, yet less studied, type III-A CRISPR-Cas system, and understand its implications during CRISPR-Cas defense and tolerance. Preliminary work on the type III-A system of Staphylococcus epidermidis revealed that this system preferentially acquires new spacers by two independent modes. The first mode acquires spacers from some, but not all, highly transcribed genes, and spans their entire transcribed region. The first aim of this proposal is to elucidate how the acquisition machinery recognizes specific genes as substrates for preferential acquisition. This will be achieved by dissecting the DNA sequences that recruit the spacer-integrase complex to specific genes, finding host factors that mediate gene-specific spacer acquisition, and test for the physiological relevance of this process during the CRISPR-Cas immune response. The second mode of acquisition by the type III-A system is similar to the previously studied type I and II systems, where spacers are acquired from free dsDNA ends at the bacterial chromosomal terminus, in a manner that is dependent on the cell’s DNA-repair machinery. Such self-targeting spacers are expected to induce autoimmunity and be negatively selected, however we found them to be stably fixed in the bacterial population, suggesting the existence of unknown mechanisms that inhibit targeting by Cas nucleases at this site, thus preventing CRISPR autoimmunity. The second aim of this proposal will define the genomic context that allows self-targeting spacers to be tolerated, analyze the temporal dynamics of CRISPR- Cas immunity at free DNA ends, and explore the genetic components needed for CRISPR-tolerance and accumulation of self-targeting spacers. This proposed work will not only transform our conceptual understanding of the spacer acquisition process, but also could lead to CRISPR-based technological developments in molecular biology and diagnostics. To achieve these goals, I have assembled a team of experts in the fields of transcription, DNA repair, bioinformatics, biochemistry and biophysics. Their guidance, along with the continued mentorship of Prof. Luciano Marraffini and the scientific environment of the Rockefeller University, will allow me to perform the proposed research, as well as to develop writing, mentorship and communication skills, that will support my successful transition to an independent career.

项目总结